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ORIGINAL ARTICLE
Shock Waves Induce Activity of Human Osteoblast-Like Cells in
Bioactive Scaffolds
Giuliana Muzio, PhD, Enrica Verne`, PhD, Rosa Angela Canuto, MD, Germana Martinasso, PhD,
Silvia Saracino, Dr, Francesco Baino, Dr, Marta Miola, PhD, Laura Berta, MD, Roberto Frairia, MD,
and Chiara Vitale-Brovarone, PhD
Background: Bone replacement is frequently needed in periodontal, ortho-
pedic, and maxillofacial diseases. To avoid complications with autografts
and allografts, artificial grafts (scaffolds) are candidates for stimulating bone
regeneration after colonization with osteoblasts. Moreover, osteoblast activ-
ity can be induced by biological or physical stimulation. In this research,
extracorporeal shock waves were used to improve the ability of human
osteoblasts to colonize scaffolds and to induce their osteogenic properties.
Methods: Osteoblasts, treated with shock waves, were seeded on glass-
ceramic macroporous scaffolds. Cells in scaffolds were counted after detach-
ment and examined for calcium nodule formation (Alizarin staining), for
differentiation markers (real time polymerase chain reaction), and for scaf-
fold colonization (scanning electron microscope).
Results: Shock waves initially increased both the number and the activity of
osteoblasts in the scaffold, but subsequently increased only osteoblast activity.
Moreover, shock waves favored scaffold colonization even in the deeper layers.
Conclusions: The calcium deposits and differentiation markers studied have
demonstrated that shock waves increase osteoblast migration and penetration
into scaffolds.
Clinical Relevance: This study may provide an important starting point for
the introduction of shock waves to boost bone formation through osteoblast
stimulation in diseases characterized by bone defects.
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Bone replacements are needed in cases of trauma, neopla-sia, and in many periodontal diseases and orthopedic and
in maxillofacial surgery.1–3
At present, most injuries are not adequately treated
because bone defects of critical size cannot be repaired by
natural bone growth.4 Furthermore, because of the increase in
mean population age and in surgery for removing tumors,
bone regeneration is a clinical need of growing importance.5
Autografts, allografts, or xenografts can be used as bone
substitutes. The high degree of osteoinduction and osteogen-
esis obtained by autograft makes it the ideal choice. However,
it presents some drawbacks, including scarce availability, the
need for a second surgical operation, and donor site morbid-
ity.6–8 Allografts and xenografts, which can overcome these
problems, are characterized by poorer bone induction, lower
integration rate, by no means of negligible contamination
risk, immune rejection, and viral transmission.9,10 For these
reasons, artificial grafts (scaffolds) are interesting and chal-
lenging candidates for stimulating bone regeneration and
supporting newly formed bone.1–4,11
In previous works,12,13 three-dimensional bioactive
glass-ceramic scaffolds were successfully obtained by the
sponge impregnation method using a polymeric template.
These scaffolds, showing pores in the 100-m to 500-m
range and trabecular morphology analogous to spongy bone,
were highly bioactive as they induced the precipitation of
hydroxyapatite on their surfaces. They were also osteoinduc-
tive, as evinced by osteoblast proliferation within the scaffold
and synthesis of calcium nodules. Because these scaffolds are
interesting candidates for bone tissue engineering applica-
tions, in this research, human osteoblast-like cells were ex-
posed to shock waves before seeding on the scaffold to
increase their osteogenic activity.
The adoption of shock waves to induce bone synthesis
was prompted by several considerations. Extracorporeal shock
waves were originally introduced in medical therapy to disin-
tegrate calcific deposits within renal, biliary, and salivary
tracts.14,15 More recently, shock waves have also been in-
creasingly applied in various musculoskeletal disorders.16,17
Extracorporeal shock wave treatment has also been
shown to increase the expression of bone morphogenetic
protein (BMP)-2, -3, -4, and -7 in rats with femoral defects.18
In vitro studies on human osteoblast-like cells have
shown that treatment with shock waves influences cell pro-
liferation enhancing the transmembrane currents and the
voltage dependence of Ca-activated and K channels.19
Since at the moment little is known about the parame-
ters regarding osteoblast activity induced by shock waves, in
this study, we have evaluated alkaline phosphatase (ALP),
osteocalcin, type I collagen, BMP-4 and -7, and calcium
deposits.
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MATERIALS AND METHODS
Scaffold Preparation
Glass-ceramic macroporous scaffolds were obtained
using an organic template (polyurethane sponge) and bioac-
tive glass powders, as previously reported.12,13 The scaffolds
(1 cm3) were soaked in Tris-buffered simulated body fluid
before cell seeding to stimulate the precipitation of the
hydroxyapatite layer, known to favor bone formation.
Cell Culture Conditions
Human osteoblast-like cell line, MG-63 (ATCC, Rock-
ville, MD), was grown in minimum essential medium (MEM)
medium containing 2 mmol/L L-glutamine, 1% (v/v) antibiotic/
antimycotic solution, 1 mmol/L sodium pyruvate, and 10%
(v/v) fetal bovine serum in an atmosphere of 5% CO2 and
95% air at 37°C.
Treatment of Cells With Shock Waves
The shock wave generator used was a piezoelectric
device (Piezoson 100, Richard Wolf, Knittlingen, Germany)
designed for clinical use in orthopedics and traumatology.
The instrument generates focused underwater shock waves at
various frequencies (1–4 impulses/s) and intensities (0.05–
1.48 mJ/mm2). For medical use, in orthopedics, shock waves
of 0.01 mJ/mm2 to 0.6 mJ/mm2 are applied.20
The experimental setup has been previously reported.21
Briefly, each cell-containing tube was placed vertically. The
shock wave unit was kept in contact with the cell-containing
tube by means of a water-filled cushion. Common ultrasound
gel was used as a contact medium between cushion and tube.
MG-63 cells (106/mL) were exposed to shock waves at
different energy levels ranging from 0.08 mJ/mm2 to 0.32
mJ/mm2. For each energy level, different numbers of im-
pulses were tested (from 50 to 1,000 at 4 impulses/s). MG-63
cells, exposed or not to shock waves, were seeded (10,000
cells/cm2) in multiwells and used for counting cell numbers
and analyzing viability up to 10 days, to identify the shock
wave exposure able to increase cell proliferation. After these
preliminary experiments, only shock wave treatment corre-
sponding to 0.22 mJ/mm2 and 100 total impulses was used
(named E6 100).
Cell Growth Within Scaffolds
Sterilized scaffolds, pretreated in simulated body fluid
for 1 week, were preconditioned for 24 hours in multiwells
containing culture medium. After removing preconditioning
medium, MG-63 cells, treated with shock waves (0.22 mJ/
mm2 and 100 total impulses) or not (control cells), were
seeded (10,000 cells/cm2) on the scaffolds.
Six, 10, and 20 days after cell seeding, the medium was
removed and the scaffolds were used to count the cells that
had grown within them and to evaluate cell viability, mor-
phology, presence of calcium deposits, and osteoblast activity
parameters. With this aim, the scaffolds were treated with
trypsin/ethylenediaminetetraacetic acid (0.25%/0.3%) to har-
vest the cells present within them.
Cell Count and Viability
Cells were counted in a Burker chamber by using a
light microscope (Leitz, Wetzlar, HM-LUX, Germany). To
determine viability, plasma membrane integrity was checked
microscopically by trypan blue exclusion test (dye concen-
tration 0.8 mg/mL); 400 cells were counted for each sample
and results were expressed as percentages of trypan blue-
positive cells.
Calcium Deposit Evaluation
The determination of calcium deposits was performed
on cells grown within the scaffolds. After trypsinization, fixation
in 70% ethanol and washing with Tris-buffered saline, cells were
stained with 1% Alizarin red S for 2 minutes, washed with
Tris-buffered saline, and observed under light microscope.22
Morphology Evaluation by Scanning Electron
Microscope
At the different experimental times, scaffolds not treated
with trypsin (containing cells), scaffolds not containing cells
(negative control), and scaffolds after treatment with trypsin to
remove cells were rinsed four times in phosphate-buffered
saline and fixed with 2.5% glutaraldehyde in 0.1 mol/L
phosphate buffer (pH 7.4) for 30 minutes at 4°C. Dehydration
was performed with water replacement by a series of graded
ethanol solutions with final dehydration in absolute ethanol.
Cross-sections of the scaffolds were then gold sputtered for
scanning electron microscope (SEM) observation.
Evaluation of Osteoblast Activity Parameters
by Real-Time Polymerase Chain Reaction
After 6 days and 20 days, cells detached from scaffolds
were examined for osteoblast-activity parameters: ALP, osteo-
calcin, type I collagen, BMP-7 and -4. Total RNA was extracted
using RNeasy Mini Kit (QIAGEN, GmbH, Germany).
Real-time polymerase chain reaction (PCR) was per-
formed using single-stranded cDNA prepared from total
RNA (1 g) with the High-Capacity cDNA Archive kit
(Applied Biosystems, Foster City, CA). Forward and reverse
primers were designed using Beacon Designer software (Bio-
Rad, Hercules, CA; Table 1).
Twenty-five microliter of a PCR mixture, containing
cDNA template equivalent to 80 ng of total RNA, 5 pmoles
each of the forward and reverse primers, and 2 iQ SYBR
Green SuperMix (Bio-Rad, Hercules, CA), were amplified
using an iCycler PCR (Bio-Rad, Hercules, CA). Each sample
of the three different experiments was tested six times and the
threshold cycle (Ct) values were the corresponding mean. The
fold change was defined as the relative expression compared
with that at time 0 (time of seeding cells), calculated as 2Ct,
where Ct  Ctsample  CtGAPDH and Ct  Ctsample 
Ct
time 0
. Data are reported as variation percentages, calculated
taking the values of control cells as 100.
Statistical Analysis
All data were expressed as means  SD of three
different experiments. The significance of differences be-
tween group means was assessed by variance analysis, fol-
lowed by the Newman-Keuls test (p  0.05).
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RESULTS
Human osteoblast-like cells, MG-63, were treated with
shock waves at different energy levels. For each energy level,
the effect on cell proliferation of different numbers of im-
pulses (ranging from 50 to 1,000, 4 impulses/s) was tested
(data not shown). On the basis of these preliminary experi-
ments, the energy level and the number of impulses required
to stimulate cell proliferation were identified (0.22 mJ/mm2
per 100 impulses, named E6 100) and adopted in subsequent
experiments. Immediately after shock wave exposure, this
experimental condition caused a decrease in cell viability
(23%), then a significant increase in cell number, as shown
in Figure 1 (panel A), and finally a tendential although not
significant increase in the number of cell divisions (panel B).
Increase in cell number reached the highest value 10 days
after shock wave treatment. The variation percentage calcu-
lated for treated cells was 125%, taking the values of control
cells as 100. Viability during all experimental times was the
same for cells treated with shock waves and control cells and
remained about 100% (data not shown). The tendential in-
TABLE 1. Forward and Reverse Primers for PCR Analysis
Gene Access (Number) Sequence Annealing (°C) Cycles
GAPDH (NM_002046) FW-5-GTC GGA GTC AAC GGA TTT GG-3 52 30
RV-5-GGG TGG AAT CAT ATT GGA ACA TG-3
ALP (NM_000478) FW-5-CTC CCA GTC TCA TCT CCT-3 58 40
RV-5-AAG ACC TCA ACT CCC CTG AA-3
Osteocalcin (NM_199173) FW-5-GTG ACG AGT TGG CTG ACC-3 59 35
RV-5-CAA GGG GAA GAG GAA AGA AGG-3
Type I collagen (NM_000089) FW-5-ACA GCC GTC TCA CCT ACA GC-3 60 45
RV-5-GTT TTG TAT TCA ATC ACT GTC TTG CC-3
BMP-7 (NM_001719) FW-5-GTG GAA CAT GAC AAG GAA T-3 58 40
RV-5-GAA AGA TCA AAC CGG AAC-3
BMP-4 (D30751) FW-5-CTC GCT CTA TGT GGA CTT C-3 58 45
RV-5-ATG GTT GGT TGA GTT GAG G-3
FW, forward primer; RV, reverse primer.
Figure 1. Osteoblast proliferation after treatment with shock waves. Panel A: Numbers of osteoblasts were counted after treat-
ment with shock waves at the energy level of 0.22 mJ/mm2 and 100 impulses (E6 100) at the indicated experimental times.
Data are means  SD of three different experiments. Panel B: Numbers of cell divisions were counted as described earlier.
Panel C: Numbers of osteoblasts, treated with shock waves (E6 100) and seeded on scaffolds, were counted at the indicated
experimental times after detachment from scaffold with trypsin. Data are means  SD of three different experiments. For each
panel, means with different letters are significantly different from one another (p  0.05) as determined by analysis of vari-
ance followed by post-hoc Newman-Keuls test.
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crease in the numbers of new cells generated after treatment
with shock waves, compared with those of the control cells,
demonstrates the entity of increased colonization of the scaf-
fold by osteoblasts as well as their stimulating effect. Figure
1 also shows the total number of cells present within the
scaffold at 6, 10, and 20 days after cell seeding (panel C). In
shock wave-treated cells, an increase in cell number was
observed at 6 days and 10 days after treatment, whereas a
decrease was observed at 20 days.
MG-63 cell spreading and migration within the scaffolds
were evaluated by SEM analysis. Different cross-sections of the
scaffolds were obtained (up to 5 mm from the surface) to
compare the depth of colonization of the shock wave-treated
cells with that of the control cells. In both cases, MG-63 cells
were observed to attach, spread, and proliferate to a greater
degree at 10 days and 20 days than at 6 days. Moreover, SEM
analysis showed that at 10 days and 20 days, shock wave-
treated cells that penetrated to layers up to 5-mm deeper than
control cells, which were only found on the surface. Figures
2 and 3 report SEM micrographs of the surface and of the
deepest layer (5 mm) of the scaffolds at 10 days and 20 days,
respectively. The cells colonizing the scaffold strongly ad-
hered to its porous structure and appeared to be closely
attached to the surface.
To determine the mineralization process, calcium de-
posits were shown up by staining the cells harvested from the
scaffolds with Alizarin red S. Histochemical analysis (Fig. 4)
showed that after 10 days, a few Alizarin-positive areas had
developed only in scaffolds colonized by shock wave-treated
cells; at 20 days, calcium deposits were observed in both
control and shock wave-treated cells, but they were more
Figure 3. Osteoblast spreading and migration onto the scaf-
folds evaluated by SEM analysis at 20 days. SEM micro-
graphs of the surface and of deepest layer (5 mm) of the
scaffolds show the osteoblasts treated (E6 100) or not
treated with shock waves at 20 days after seeding on the
scaffolds. Arrows indicate cells.
Figure 4. Calcium deposits evidenced with Alizarin S stain-
ing. Osteoblasts harvested from the scaffolds were stained
with Alizarin red S and observed at light microscope. The
cells treated (E6 100) or not treated with shock waves were
harvested at 10 days and 20 days after seeding on the scaf-
folds. Arrows indicate calcium deposits.
Figure 2. Osteoblast spreading and migration onto the scaf-
folds evaluated by SEM analysis at 10 days. SEM micro-
graphs of the surface and of deepest layer (5 mm) of the
scaffolds show the osteoblasts treated (E6 100) or not
treated with shock waves at 10 days after seeding on the
scaffolds. Arrows indicate cells.
Canuto et al. The Journal of TRAUMA® Injury, Infection, and Critical Care • Volume XX, Number XX, XXX 2010
© 2010 Lippincott Williams & Wilkins4
frequent and larger in scaffolds containing shock wave-
treated cells.
Markers of osteoblast activity were also examined. ALP,
type I collagen, BMP-7, -4, and osteocalcin mRNA were eval-
uated by real-time PCR at 6 days and 20 days after shock wave
exposure. Figure 5 shows that all the parameters examined were
higher in shock wave-treated cells than in control cells, except
for type I collagen at 6 days, BMP-7, and -2 at 20 days, when the
values were 120%, 90%, and 53%, respectively, with control
cell values taken as 100. The percentage values of increased
gene expressions in treated cells were at 6 days, 200% for ALP,
173% for osteocalcin, 283% for BMP-4, 152% for BMP-7, and
141% for BMP-2; at 20 days, 422% for ALP, 312% for type I
collagen, 207% for osteocalcin, and 230% for BMP-4.
DISCUSSION
Current opinion holds that significant improvements in
bone regeneration will be obtained only by using new technol-
ogies based on tissue engineering supported by biochemical or
biophysical stimulation. This science requires three-dimensional
scaffolds able to mimic bone and to be colonized by osteoblast-
like cells and their products. Among possible forms of biophys-
ical stimulation, shock waves have recently been applied in a
broad range of musculoskeletal pathologies,16,17 even though
some aspects of the mechanisms involved are still unclear. In
this research, it has been found that treating human osteoblast-
like cells, MG-63, with shock waves generated by a piezo-
electric apparatus produces an increase in the number of
osteoblasts and their degree of penetration into the scaffold.
Regarding the increase in osteoblast number, the effect was
different at various experimental times: at the earlier times (6
days and 10 days after shock wave exposure), numbers of
shock wave-treated cells present within the scaffold were
higher than those of control cells, whereas at the last exper-
imental time (20 days), the numbers were lower than in the
controls. Conversely, it has been shown that there were more
Figure 5. Alkaline phosphatase (ALP), osteocalcin, type I collagen, bone morphogenetic protein (BMP)-4, -7, and -2 mRNA con-
tent. mRNA content, at 6 days and 20 days after seeding cells on scaffolds, was evaluated by real-time PCR and the values of osteo-
blasts treated with shock waves (E6 100) were referred to those of control cells taken as 100% (black line). Data are means  SD of
three different experiments. For each panel, means with different letters are significantly different from one another (p  0.05) as
determined by analysis of variance followed by post-hoc Newman-Keuls test. The control values are indicated as a.
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and larger calcium deposits present in scaffolds colonized by
shock wave-treated cells than those produced by control cells.
In the light of these observations, we supposed that shock
wave-treated cells at 20 days might proliferate less but function
more actively. To measure the parameters induced by shock
waves resulting in an increased osteogenic activity of MG-63
cells, some markers have been studied. It has emerged that
MG-63 cells exposed to shock waves expressed more ALP,
osteocalcin, type I collagen, and all BMP-4, -7, and -2. ALP,
type I collagen, and osteocalcin showed the highest increase
after 20 days, whereas BMP-4, -7, and -2 showed the highest
increase after 6 days with a decrease after 20 days. It is known
that ALP expression, which is an early marker of osteoblast
differentiation, could be increased by BMP-4.23,24
BMPs enable skeletal tissue formation during embryo-
genesis, growth, adulthood, and healing. BMPs (BMP-2, -4,
and -7) are the only growth and differentiation factors, which
can singly induce de novo bone formation both in vitro and at
heterotopic sites in vivo.25 After a fracture, BMPs apparently
diffuse from reabsorbing bone matrix and activate osteopro-
genitor cells which, in turn, produce more BMPs. The tem-
poral and spatial distribution of the BMPs during fracture
healing have been moderately well characterized as a com-
plex, interactive, and site-specific process.26–28
The observations described earlier suggest that shock
waves initially induce an increase in cell number and osteogenic
activity, whereas induction of osteogenic activity prevails later.
This research has shown that the use of physical stimulus,
such as shock waves, induces osteoblast activity producing the
same effect as using biological molecules, such as BMP-2, an
osteoinductive growth factor able to determine osteoblast differ-
entiation by increasing calcium deposits and accelerating the
healing process when implanted in a bone defect. Our previous
article12 described how in scaffolds colonized with human
osteoblast-like cells treated with BMP-2, more and larger calcium
deposits were produced than in the controls, suggesting that the
higher degree of mineralization ability of the cells, although
there was only a small number of them in the scaffold, was
attributable to the BMP-2. In the same way, in SEM analysis,
osteoblast-like cells were observed to attach, spread, proliferate,
and form mineralized nodules when cultured on bioactive scaf-
folds to a greater extent in BMP-2–treated cells than in con-
trols.12 Therefore, shock waves treatment may be assumed to
provide a good opportunity to stimulate osteoblast activity,
preferable to the use of chemical substances.
It should be noted that the importance of the use of
shock waves lies in their ability to stimulate scaffold coloni-
zation and migration: shock wave-treated cells have been
found to penetrate further into scaffolds, whereas untreated
cells remain on the surface.
These encouraging results have led us to conclude that this
study may well provide an important point of departure in the
introduction of shock waves to enhance bone healing through
osteoblast activity in bioactive glass-ceramic scaffolds.
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